AbstractObjectivesTo develop a stochastic population model of disease progression in chronic obstructive pulmonary disease (COPD) that includes the effects of COPD exacerbations on health-related quality of life, costs, disease progression, and mortality and can be used to assess the effects of a wide range of interventions.MethodsThe model is a multistate Markov model with time varying transition rates specified by age, sex, smoking status, COPD disease severity, and/or exacerbation type. The model simulates annual changes in COPD prevalence due to COPD incidence, exacerbations, disease progression (annual decline in the forced expiratory volume in 1 second as percentage of the predicted value), and mortality. The main outcome variables ar...
This study evaluates the costs and utilities of different treatment strategies for stable chronic ob...
Objectives: 1) To improve an existing COPD model by incorporating the distinction between mild, mode...
OBJECTIVES: To compare different chronic obstructive pulmonary disease (COPD) cost-effectiveness mod...
Objectives: To develop a stochastic population model of disease progression in chronic obstructive p...
Objectives: To develop a stochastic population model of disease progression in COPD that includes th...
Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth leading cause of de...
AbstractChronic obstructive pulmonary disease (COPD) is a chronic lung disease that is thought to af...
Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible lung disease characte...
Background. To develop statistical models predicting disease progression and outcomes in chronic obs...
BACKGROUND: To develop and validate a new conceptual model (CM) of chronic obstructive pulmonary dis...
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible disease r...
Background The increase in costs related to the diagnosis and treatment of chronic-degenerative dise...
The medico-economic impact of smoking cessation considering a smoking patient with chronic obstructi...
OBJECTIVES: To assess how suitable current chronic obstructive pulmonary disease (COPD) cost-effecti...
The aim was to estimate the economic burden, as well as rate of progression of COPD for a cohort of ...
This study evaluates the costs and utilities of different treatment strategies for stable chronic ob...
Objectives: 1) To improve an existing COPD model by incorporating the distinction between mild, mode...
OBJECTIVES: To compare different chronic obstructive pulmonary disease (COPD) cost-effectiveness mod...
Objectives: To develop a stochastic population model of disease progression in chronic obstructive p...
Objectives: To develop a stochastic population model of disease progression in COPD that includes th...
Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth leading cause of de...
AbstractChronic obstructive pulmonary disease (COPD) is a chronic lung disease that is thought to af...
Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible lung disease characte...
Background. To develop statistical models predicting disease progression and outcomes in chronic obs...
BACKGROUND: To develop and validate a new conceptual model (CM) of chronic obstructive pulmonary dis...
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible disease r...
Background The increase in costs related to the diagnosis and treatment of chronic-degenerative dise...
The medico-economic impact of smoking cessation considering a smoking patient with chronic obstructi...
OBJECTIVES: To assess how suitable current chronic obstructive pulmonary disease (COPD) cost-effecti...
The aim was to estimate the economic burden, as well as rate of progression of COPD for a cohort of ...
This study evaluates the costs and utilities of different treatment strategies for stable chronic ob...
Objectives: 1) To improve an existing COPD model by incorporating the distinction between mild, mode...
OBJECTIVES: To compare different chronic obstructive pulmonary disease (COPD) cost-effectiveness mod...